Zdrowie i gospodarka · 16/01/2008

FDA Announces Cancellation of User Fee Program for Direct-to-Consumer TV Ads for Prescription Drugs

The FDA is issuing a notice to inform companies that the Direct-to-Consumer television advertisement user fee program for prescription drug and biological products will not be implemented due to insufficient funding, as required by the Food and Drug Administration Amendments Act of 2007.